LLY and 0ACX Related Headlines
Go Back- Lilly completes acquisition of Centessa Pharmaceuticals
- Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
- Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
- Lilly to acquire Centessa for $6.3 billion to expand sleep disorder treatments
- Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
LLY and 0ACX Related Press Releases
Go Back- Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
- Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
- Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
